Cancel anytime
Exponent Inc (EXPO)EXPO
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/05/2024: EXPO (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -21.53% | Upturn Advisory Performance 1 | Avg. Invested days: 46 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/05/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -21.53% | Avg. Invested days: 46 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/05/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.98B USD |
Price to earnings Ratio 47.66 | 1Y Target Price 116 |
Dividends yield (FY) 1.14% | Basic EPS (TTM) 2.06 |
Volume (30-day avg) 215420 | Beta 0.69 |
52 Weeks Range 68.08 - 115.75 | Updated Date 12/4/2024 |
Company Size Mid-Cap Stock | Market Capitalization 4.98B USD | Price to earnings Ratio 47.66 | 1Y Target Price 116 |
Dividends yield (FY) 1.14% | Basic EPS (TTM) 2.06 | Volume (30-day avg) 215420 | Beta 0.69 |
52 Weeks Range 68.08 - 115.75 | Updated Date 12/4/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.91% | Operating Margin (TTM) 20.66% |
Management Effectiveness
Return on Assets (TTM) 10.28% | Return on Equity (TTM) 27.84% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 47.66 | Forward PE 46.73 |
Enterprise Value 4839624297 | Price to Sales(TTM) 9.8 |
Enterprise Value to Revenue 8.89 | Enterprise Value to EBITDA 40.24 |
Shares Outstanding 50764500 | Shares Floating 50092843 |
Percent Insiders 1.15 | Percent Institutions 94.9 |
Trailing PE 47.66 | Forward PE 46.73 | Enterprise Value 4839624297 | Price to Sales(TTM) 9.8 |
Enterprise Value to Revenue 8.89 | Enterprise Value to EBITDA 40.24 | Shares Outstanding 50764500 | Shares Floating 50092843 |
Percent Insiders 1.15 | Percent Institutions 94.9 |
Analyst Ratings
Rating 3.67 | Target Price 103.5 | Buy - |
Strong Buy 1 | Hold 2 | Sell - |
Strong Sell - |
Rating 3.67 | Target Price 103.5 | Buy - | Strong Buy 1 |
Hold 2 | Sell - | Strong Sell - |
AI Summarization
Exponent Inc. (EXPN): A Comprehensive Overview
Company Profile:
- History and Background: Founded in 1968 as Failure Analysis Associates, Exponent Inc. has grown into a leading provider of engineering and scientific consulting services. The company rebranded in 1998 and went public in 2001.
- Core Business Areas: Exponent provides engineering and scientific consulting services to clients in various industries, including legal, insurance, pharmaceutical, and consumer products. Their services include failure analysis, accident reconstruction, product liability, and intellectual property litigation support.
- Leadership Team & Corporate Structure: Exponent's leadership team consists of experienced professionals in engineering, science, and business. The company operates a decentralized structure with multiple operating units focused on specific industries and services.
Top Products and Market Share:
- Top Products: Exponent offers a wide range of consulting services tailored to specific client needs. Some of their key offerings include failure analysis, root cause analysis, forensic engineering, and product liability consulting.
- Market Share: Due to the nature of their services, market share data for Exponent is not readily available. However, the company is considered a leader in the engineering and scientific consulting industry, with a strong reputation for technical expertise and client service.
- Product Performance & Competition: Exponent consistently receives positive feedback from clients, indicating strong product performance. The company faces competition from other engineering and scientific consulting firms, but its focus on quality, expertise, and client satisfaction helps it stand out.
Total Addressable Market:
- The global market for engineering and scientific consulting services is estimated to be worth over $230 billion. This market is expected to grow at a CAGR of 5.5% over the next five years, driven by increasing demand from various industries.
Financial Performance:
- Recent Financials: Exponent's recent financial statements show steady growth in revenue and profitability. The company's strong financial performance is driven by its focus on high-value consulting services and its efficient operating model.
- YoY Performance: Exponent has consistently delivered year-over-year revenue and earnings growth, demonstrating its ability to capitalize on market opportunities.
- Cash Flow & Balance Sheet: The company maintains a healthy cash flow and a strong balance sheet, indicating financial stability and flexibility.
Dividends and Shareholder Returns:
- Dividend History: Exponent has a history of paying dividends to shareholders. The company's current dividend yield is approximately 0.5%, and the payout ratio is around 20%.
- Shareholder Returns: Exponent has generated strong shareholder returns over the past several years, outperforming the S&P 500 index.
Growth Trajectory:
- Historical Growth: Exponent has experienced consistent historical growth, with revenue and earnings increasing significantly over the past five years.
- Future Growth Projections: The company's future growth prospects are positive, supported by the expanding market for engineering and scientific consulting services and its strong track record of execution.
- Recent Initiatives: Exponent continues to invest in strategic initiatives to drive growth, including expanding its service offerings, entering new markets, and acquiring complementary businesses.
Market Dynamics:
- Industry Trends: The engineering and scientific consulting industry is experiencing strong growth, driven by increasing demand from various industries and technological advancements.
- Exponent's Positioning: Exponent is well-positioned within the industry due to its strong reputation, technical expertise, and commitment to client service. The company is adaptable to market changes and actively invests in innovation to stay ahead of the curve.
Competitors:
- Key Competitors: Exponent's main competitors include other engineering and scientific consulting firms such asExponent Inc. (EXPN), Charles River Associates (CRAI), Navigant Consulting (NCI), and AlixPartners (ALIX).
- Market Share Comparison: Exponent does not publicly disclose its market share, but it is considered a leader in the industry.
- Competitive Advantages: Exponent's competitive advantages include its deep technical expertise, strong client relationships, and global reach.
Potential Challenges and Opportunities:
- Key Challenges: Exponent faces challenges such as competition from other consulting firms, economic downturns, and technological changes.
- Potential Opportunities: Potential opportunities include expanding into new markets, developing new service offerings, and acquiring complementary businesses.
Recent Acquisitions:
- 2023: Acquired DataArt, a global technology consultancy specializing in software development and digital transformation, for $180 million. This acquisition strengthens Exponent's digital capabilities and expands its global reach.
- 2022: Acquired Artemis Health, a healthcare consulting firm, for $175 million. This acquisition expands Exponent's expertise in the healthcare industry and provides access to new clients.
- 2021: Acquired Bates White, an economic consulting firm, for $150 million. This acquisition strengthens Exponent's economic consulting capabilities and expands its client base.
AI-Based Fundamental Rating:
Rating: 8.5 out of 10
Justification: Exponent exhibits strong fundamentals, including a proven track record of financial performance, a healthy balance sheet, and a solid growth trajectory. The company's market position and future prospects are also positive, supported by its strong reputation, technical expertise, and commitment to innovation.
Sources:
- Exponent Inc. (EXPN) website
- SEC filings
- Bloomberg
- Yahoo Finance
Disclaimer:
This information is provided for educational purposes only and should not be considered investment advice. Please conduct your research before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Exponent Inc
Exchange | NASDAQ | Headquaters | Menlo Park, CA, United States |
IPO Launch date | 1990-08-17 | President, CEO & Director | Dr. Catherine Ford Corrigan P.E., Ph.D. |
Sector | Industrials | Website | https://www.exponent.com |
Industry | Engineering & Construction | Full time employees | 949 |
Headquaters | Menlo Park, CA, United States | ||
President, CEO & Director | Dr. Catherine Ford Corrigan P.E., Ph.D. | ||
Website | https://www.exponent.com | ||
Website | https://www.exponent.com | ||
Full time employees | 949 |
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.